Scope and Editorial Policy The mission of the Journal, WomensHealthSection.com is to publish and disseminate scientifically rigorous public health information, with special focus on women’s health, of national and international significance that enables health care providers, policy-makers, and researchers to be more effective. It aims to improve health, particularly among disadvantaged populations in both developed and developing countries. Women’s Health and Education Center (WHEC) welcomes unsolicited manuscripts, which are initially screened in-house for originality and relevance. Manuscripts passing the initial screening are sent blindly for peer review. After the reviews have been received, the editorial advisers decide on the manuscript’s acceptability for publication in WomensHealthSection.com. Accepted papers are subject to editorial revision, including shortening of the text and omission of tables and figures if appropriate. The word limits shown below do not include the abstract (where applicable), tables, figures and references. The principal types of manuscripts are outlined below. I. Unsolicited Manuscripts 1.1 Letters. Useful contributions referring to something published recently in the WomensHealthSection.com or WHEC Update; 400-850 words, maximum 3 references. Letters are also edited and may be shortened. 1.2 Policy & Practice. Reviews, debates or hypothesis-generating papers; not more than 3,000 words, with a non-structured abstract (see below 3.5) and not more than 25 references; peer reviewed. 1.3 Research. Methodologically sound primary research of relevance to women’s health and health development. Formal scientific presentations of not more than 3,000 words, with a structured abstract (see below) and not more than 25 references; peer reviewed. 1.4 Systematic reviews in women’s health. Exhaustive, critical assessments of published and unpublished studies (grey literature) on research questions of relevance to women’s health and practice are welcome. Reviews should be prepared in strict compliance with MOOSE or QUOROM (PRISMA) guidelines or with Cochrane’s complementary guidelines for systematic reviews of health promotion and public health interventions. Not more than 3,000 words and 25 references, plus a 250-word structured abstract (see below 3.5). All studies included and excluded in the review should be shown in a flow diagram that will not count towards the word limit if published as an appendix only in the electronic version of the journal or on the author’s URL. Peer reviewed. 1.5 Perspectives. Views, hypotheses or discussions (with clear message) of an issue of women’s health interest; up to 1,500 words, no more than 6 references. 1.6 Lessons from the field. Papers that capture experiences and practice gained in solving specific women’s health problems in both developed and developing countries, with a structured abstract (see below); not more than 1,500 words and not more than 10 references, with no more than one table and one figure. II. Commissioned manuscripts The categories of articles shown below are normally commissioned by the editors. Authors wishing to submit and unsolicited manuscript to be considered for one of these categories should first contact editorial office. 2.1 Editorials. Authoritative reviews, analyses or views of an important topic related to the various themes in women’s health or an important health development subject; not more than 800 words, maximum 6 references. 2.2 Round tables. Consist of a base paper on a controversial subject of current women’s health issue of national and international importance (not more than 2,000 words and an abstract) and a debate on it by several discussants, who are invited to contribute not more than 500 words each. 2.3 Books & electronic media. Reviews of a book, web-site, CD-ROM, etc. of women’s health interest; 400-800 words, no references. 2.4 Current commentaries. Explanatory or critical analysis of an individual article; not more than 800 words, maximum 6 references. 2.5 Public health classics. A landmark public health paper which focuses on women’s health and achieving universal access to reproductive health or publication is reproduced, accompanied by a commentary of up to 1,500 words. III. Preparation and Submission of Manuscripts Manuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals established by the Vancouver Group (International Committee of Medical Journal Editors, ICMJE). The complete document, updated October 2007, is available at: http://www.icmje.org 3.1 Languages. Manuscripts should be submitted in English. Authors who have difficulty in preparing their manuscript in English should contact the editorial office for advice. 3.2 Authorship. Authors should give their full names and the name and address of their institutions. If possible, only one institution per author should be given. In accordance with the «Uniform requirements» (see above), each author should have participated sufficiently in the work being reported to take public responsibility for the content; each author should provide a description of his or her contribution to the work being reported. The full postal and e-mail address of the corresponding author will be published unless otherwise requested. The WomensHealthSection.com encourages submissions from authors in developing countries, and in line with this policy at least one author should be a national of the country where the study was carried out and have an affiliation there. 3.3 Automatic links: All links inserted by the automatic reference and footnote facilities of word-processing software must be removed before the manuscript is submitted. Footnotes are not permitted and such material should be inserted into the main text. 3.4 Tables and figures: Tables and figures should be used only if they enhance understanding of the text. In the text, tables and figures should be numbered consecutively (e.g. Table 1, Fig. 1). They should be presented with clear, concise titles at the end of the text and not incorporated or embedded into it. Abbreviations or acronyms should be avoided but if used must be explained. Graphs or figures, which should be presented in two-dimensional and not pseudo three-dimensional «perspective» format, should be clearly drawn and all the data identified. 3.5 Abstracts. Abstracts, which should be clearly written to highlight the text’s most significant points, should be provided for the following types of papers: Research, Systematic reviews, Policy & practice, base papers for Round tables and Lessons from the field. The abstract, which should not exceed 250 words, appears in WomensHealthSection.com and WHEC Update. 3.6 Competing interest. A competing interest arises when a professional judgment concerning a primary interest (such as patient’s welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). We ask all authors to disclose at the time of submission any competing interests that may have. Examples of types of competing interests may be found at: http://www.icmje.org. 3.7 Funding. Authors should declare sources of funding for the work undertaken; affirm that they have not entered into an agreement with the funding organization that may have limited their ability to complete the research as planned, and that they have had full control of all primary data. 3.8 Ethical issues. The Women’s Health and Education Center (WHEC) publishes the results of research involving human subjects only if it has been conducted in full accordance with ethical principles, including the provisions of the World Medical Association Declaration of Helsinki (as amended by the 59th General Assembly, October 2008; available at: http://www.wma.net/ ) and the additional requirements, if any, of the country in which the research was carried out. Any manuscript describing the results of such research that is submitted for publication must contain a clear statement to this effect, specifying that the free and informed consent of the subjects or their legal guardians was obtained and that the relevant institutional or national ethical review board approved the investigation. 3.9 Maps. Use of maps should be avoided, but should their use be necessary authors are requested to use the relevant UN-approved maps, which can be downloaded from: http://www.un.org/Depts/Cartographic/english/htmain.htm 3.10 Bibliographic references. Authors are responsible for the accuracy of all references, which should be verified at: http://www.ncbi.nlm.nih.gov : these are not checked by editors. References should be numbered consecutively as they occur in the text (in superscript roman type, preferably at the end of a sentence) and listed in numerical order at the end of the text. WomensHealthSection.com adheres closely to the Vancouver style of references (see http://www.icmje.org updated October 2007). The first three authors of a work should be named, followed by «et al». If there are more than three.Read More
THE WOMEN’S HEALTH AND EDUCATION ORGANIZATION, INC. [Read the WHEO, Inc. Mission Statement] AND WOMEN’S HEALTH AND EDUCATION CENTER (WHEC) NGO in Special Consultative Status with ECOSOC of the United Nations AND WomensHealthSection.Com BY-LAWS Article I Name and Location 1.1 Name: The name of this non-profit organization is, THE WOMEN’S HEALTH AND EDUCATION ORGANIZATION, INC. Its acronym is: WHEO, Inc. It is at WOMEN’S HEALTH AND EDUCATION CENTER (WHEC), NGO in Special Consultative Status with the ECOSOC of the United Nations. Their web-site domain name is: WomensHealthSection.Com. 1.2 Location: The principal office is in Longmeadow, Massachusetts (USA). The Board of Directors may change the location of the principal office, upon filing a certificate with the Secretary of State of The Commonwealth of Massachusetts (USA). Article II Purpose 2.1 Purpose: The Corporation is operating as a non- profit organization for the purpose of supporting and improving the educational opportunities and general health of women and particularly women of the developing countries. Article III Membership 3.1 Members: Any persons or institutions interested in the purpose of the corporation shall be eligible for membership. The Board of Directors may from time to time establish such classes of membership as may be appropriate. In any event, all members, regardless of classification, shall have equal voting rights. 3.2 Membership Contributions: The Directors may from time to time establish membership contributions for the various classes of membership. Notices of annual membership contributions shall be sent, to all members. Any member who fails to pay the applicable membership contribution, within three months, following the sending of notice shall be dropped from membership, and shall lose all privileges of a member of the corporation. Article IV Meetings 4.1 Annual Meeting: The annual meeting of the corporation shall be held on the third Thursday on September of each year or at such other time in the month of September as the Directors shall determine. The annual meeting may be held at the principal office of the corporation, or at such other place as the Directors may determine. 4.2 Special Meetings: Special meetings of the corporation may be called by the President, a majority of the Directors, or upon written request of the majority of the members of the corporation delivered to the President. 4.3 Notice: All meetings of the corporation shall be called by giving not less than one week’s notice to each member of the corporation by mail so far as their addressed may be known or by publication of a notice in a newspaper published in Springfield, Massachusetts. 4.4 Quorum: A simple majority of members eligible to vote shall constitute a quorum for the transaction of all business. Article V Board of Directors 5.1 Number and Election: The Board of Directors shall consist of the President, the Secretary, the Treasurer and not less than three and not more than ten other members of the corporation elected annually by the members at the annual meeting. 5.2 Tenure: The Directors elected at any annual meeting shall be elected for three years or such shorter length of term as will cause the term of office of approximately one third of the elected members of the Board to expire each year. No Director shall serve for more than six consecutive years, except that an officer may, if re-elected, continue to serve in that office for not more than three additional consecutive years. Directors who have served the maximum term may be re-elected to the Board after an interval of not less than one year. 5.3 Meetings: Meetings of the Board of Directors shall be called by the President, or upon the written request of three Directors. 5.4 Notice: Notice of all meetings of the Board of Directors shall be mailed to each Director at least seven days prior to the date of any meeting. 5.5 Quorum: A simple majority, or, if there are more than ten Directors, one-third of the then in office, shall constitute a quorum. 5.6 Powers: The Board of Directors shall have the general direction, control and management of the property and the affairs of the Society except such as are to be exercised exclusively by the members of the corporation by law or by these By-Laws. 5.7 Audit: The Board of Directors shall arrange for an annual audit of the accounts of the Treasurer and the financial affairs of the corporation. 5.8 Honorary Directors: Any Director who has served as a Director for not less three years may be elected an Honorary Director at an annual meeting. An Honorary Director shall hold office for the remainder of his or her life, unless re-elected an active Director or removed for good and sufficient cause by vote of the members of the corporation. Honorary Directors shall not be voting members of the Board of Directors. (The Honorary Chairperson shall not be considered an Honorary Director). Article VI Officers 6.1 Number and Election: The officers of the corporation shall be a President, a Secretary and a Treasurer. The officers shall be elected annually by the members at the annual meeting and shall hold office for two years, and until their successors are elected. Officers may be re-elected. The Directors may fill vacancies in any office until the next annual meeting. 6.2 Honorary Chairperson and Chairperson: The Honorary Chairperson and the Chairperson shall have the usual duties of their respective offices and such other duties as may be assigned to them from time to time by the Directors. There is no limit other than the limit placed on the term of any other Directors to their term. 6.3 President: The President shall have the usual duties of such office and such other duties as may be assigned to them from time to time by the Directors. The President shall be a member of all Committees ex officio. No President shall be elected by the members to the same office for more than six consecutive terms. The President shall be executive officer of the corporation and, subject to the instructions of the Board of Directors, shall be responsible for the general operation of the corporation. So far as possible, the President shall attend all regular meetings of the corporation, the Board of Directors, and Standing Committees. The President shall prepare agendas for the annual meeting and special meetings of the corporation and for meetings of the Board of Directors. The President shall supervise the services of any employees. 6.4 Secretary: The Secretary shall record and maintain records of all proceedings of the corporation and of the Directors. These records shall be kept at the principal office of the corporation, and shall be open at all reasonable times to the inspection of any member. The Secretary shall be responsible for notices of annual meetings and special meetings of the corporation and meetings of the Board of Directors. 6.5 Treasurer: The Treasurer shall be the chief financial officer and the chief accounting officer of the corporation. The Treasurer shall be in charge of the corporation’s financial affairs, accounts, funds, securities and valuable papers, and shall keep full and accurate records thereof. The Treasurer shall supervise the keeping of correct records of receipts and expenditures in books maintained by the corporation. The treasurer shall present a report of the financial activities of the Society at each annual meeting. If required by the Directors, the Treasurer shall give bond for the faithful performance of the duties of the office in such sums and with such surety of sureties as the Directors may direct. 6.6 Vacancy: In the event of a vacancy in any office, the Directors elect one of their numbers to fill that office until the next annual meeting. Article VII Committees 7.1 Standing Committees: The Standing Committees of the corporation shall be Executive Committee, Nominating Committee, Finance Committee, Medical Advisory Committee and Educational Advisory Committee. 7.2 Executive Committee: The Executive Committee shall consist of the Chairman, the President, the Secretary, the Treasurer, and such other Directors as the President, with consent of the other Directors, may appoint for a term of one year. Directors may be reappointed. Two thirds of the members of the Executive Committee shall constitute a quorum for the transaction of business. Except as otherwise provided by law or by these By-Laws, the Executive Committee shall have and exercise all the powers of the Board of Directors during the intervals between meetings of the Directors. All actions of the Executive Committee shall be considered for ratification or confirmation at the next successive meeting of the Board of Directors. 7.3 Nominating Committee: The Nominating Committee shall consist of three members of the corporation, who need not be Directors. One member shall be elected each year at the annual meeting of the corporation for a term of three years. Any vacancy before the end of a term shall be filled by appointment by the President until the next annual meeting, at which time a member shall be elected to fill the balance of that term. No member of the Nominating Committee shall serve for more than six consecutive years. The Nomination Committee shall nominate one of more candidates for each office to be filled at the annual meeting of the corporation, including the Nominating Committee. At least one month before the Annual Meeting, the Nominating Committee shall file all nominations with the President, who shall immediately communicate those names to the Board of Directors. Nominations for any office to be filled at the Annual Meeting of the corporation may also be made by papers signed by three or more members of the corporation filed with the President at least two weeks before the Annual Meeting. Immediately upon receiving such nominations, the President shall immediately communicate those names to the Board of Directors. 7.4 Finance Committee: The members of the Finance Committee shall be appointed by the President to serve terms of three years, or such shorter length of term as will cause the term of office of approximately one-third of the members to expire each year. Members need not be Directors, and may be reappointed. The Finance Committee shall advise the Treasurer concerning the investment and management of the corporation’s funds and securities, and provide such additional advice and assistance as the Treasurer may request. 7.5 Medical Advisory: The members of Medical Advisory Committee shall be appointed by the President to serve terms of three years, or such shorter length of term as will cause the term of office of approximately one-third of the members to expire each year. Members need not be Directors, and may be reappointed. The Medical Advisory Committee shall advise the Board of Directors on those medical matters and of medical opportunities which it thinks the corporation should engage in furtherance of its stated purpose. 7.6 Educational Advisory Committee: The members of the Educational Advisory Committee shall be appointed by the President to serve terms of three years, of such shorter length of term as will cause the term of office of approximately one-third of the members to expire each year. Members need not be Directors, and may be reappointed. The Educational Advisory Committee shall advise the Board of Directors on those educational matters and of educational opportunities which it thinks the corporation should engage in furtherance of its stated purpose. 7.7 Other Committees: The President may appoint such other committees as the President and the Directors shall determine from time to time to be advisable and necessary. The chairperson of each such committee shall be a Director, but the other members of the committee need not be Directors. Members may be reappointed to such committees. Except as otherwise specifically set forth in these By-Laws, committees shall have such duties as may be assigned to them from time to time by the Directors. Article VIII Finance 8.1 Fiscal Year: The Fiscal year of the corporation shall begin on the first day of January in each year. 8.2 Accounts: The monies of the corporation shall be deposited in the name of the corporation in such banks or other financial institutions as the Directors shall designate. Funds shall be drawn only by checks or orders signed by such persons as the Directors shall designate. 8.3 Restrictions: The corporation is organized exclusively for charitable and educational purposes as specified in Section 501(c)(3) of Internal Revenue Code, as from time to time amended, herein after referred to as the code, and it shall not be operated for profit, and the corporation will nor carry on any activities not permitted to be carried on by a corporation exempt from federal income tax under the code. No part of its net earnings shall inure to the benefit of any member, director or any officer of the corporation or any private person, except that reasonable compensation may paid for services rendered to or for the corporation. No officer, director or member of the corporation or any private individual shall be entitled to share in the distribution of any of the corporate assets on dissolution of the corporation. No part of the corporation’s activities shall be the carrying on of propaganda or otherwise attempting to influence legislation or in intervening in any political campaign on behalf of any candidate for public office. Upon dissolution, all of the remaining assets and property of the corporation, after payment of necessary expensed thereof, shall be distributed to another corporation exempt under said section of the code, to be applied by such other corporation for those purposes of that corporation that are most similar to the purposes of this corporation, and no member or officer of this corporation shall profit thereby. Article IX Amendments 9.1 By the Directors: These By Laws, or any subsequent By-Law adopted by the Directors the members, may be amended or repealed by vote of two-thirds of the Directors then in office, except with respect to any provision of any By-Law which by law, the corporation’s Articles of Incorporation, or these By Laws, require action by the members of the corporation. Written notice stating the substance of any such amendment or repeal shall be given to the members not later than the annual meeting next following the vote of the Directors to amend or repeal. 9.2 By the Members: These By Laws, or any subsequent By Law adopted by the Directors or members, may be amended or repealed by vote of two-thirds of the members present at any meeting of the corporation. Written notice that the subject of amending or repealing By Laws is to come before the corporation shall be included in the notice of such meeting. 9.3 Restrictions: No amendment may be made which affects the non-profit status of the corporation or affects the disposition of assets on dissolution of assets on dissolution to another non-profit and income-tax-exempt organization.Read More
Dr. James F. Phillips Senior Lecturer Heilbrunn Department of Population and Family Health, Mailman School of Public Health, Columbia University 60 Haven Avenue, B-317 New York, NY 10032 email — jfp2113@columbia.edu James F. Phillips is a senior associate in the Population Council’s Policy Research Division. He previously worked in the Population Council’s International Programs Division in Bangladesh, the Philippines, and Thailand. Prior to his work with the Population Council, Phillips held positions in Nigeria with the International Committee of the Red Cross and UNICEF. Dr. Phillips conducts field experiments that measure the demographic role of family planning and child survival programs. He directed Bangladesh’s Matlab Community Health and Family Planning Project which demonstrated the demographic potential of family planning services in that country. The Matlab service model became the basis for national health reform in the 1980s and 1990s. Dr. Phillips is currently working on a collaborative research program with the Ghana Health Service and the Navrongo Health Research Centre. When the Navrongo Experiment established the feasibility of reducing fertility and mortality with community-based health and family planning services in 1999, a national scaling-up initiative, known as the Community-based Health Planning and Services initiative, was launched to extend the Navrongo service model to all 110 Ghanaian districts. Phillips serves as the senior advisor to the Ghana Health Service for this program, where he collaborates on research designed to guide, refine, and evaluate the scaling-up effort. Dr. Phillips is currently collaborating with his Ghanaian colleagues on a program of exchange that will extend health service innovations from Ghana to Burkina Faso, Sierra Leone, and Ethiopia. In 2005, Dr. Phillips launched a new collaborative venture with the Vietnam Ministry of Health that aims to apply evidence-based planning methods to health reform in that country. Dr. Phillips is a member of several international science advisory boards and has launched scientific research networks on issues related to health sector reform, reproductive health, and demographic research methodology. He holds an M.S. degree in population studies from the University of Hawaii, and a Ph.D. in sociology from the University of Michigan. Phillips has published books on the evaluation of family planning programs, the demography of South Asia, and population policy in Bangladesh. He has journal publications on the demography of Asia and Africa, health policy, computer science, and other topics.Read More
Центр здоровья & образования женщин предусматривает unlimited субсидия на образование для научныа исследования и разработки е-uc4 проекта: WomensHealthSection.com. Здоровьем женщин & центром образования (WHEC) будут организация мулти-ukrepl4ht держатели и он зарегистрирован в Соединенных Штатах Америки. WHEC не имеет финансовохозяйственный интерес или affiliation с любым изготовлением коммерческих продучтов могут быть обсужены в этом издании, ни с любой из корпоративных организаций предлагая финансоваяа поддержка или субсидия на образование для WomensHealthSection.com или своей продолжая медицинской деятельности при образования. Ы, что соответствует весь рекламный материал к этичным (медицинским) стандартам, включение в этом издании не образовывает гарантию или жироприказ качества или значения такого продукта или заявок сделанных его изготовлением. Возникновение рекламы в WomensHealthSection.com или всех других изданиях здоровья женщин & центра образования (WHEC) (and/or в экспонатах на встречах WHEC) не образовывает гарантию или жироприказ качества или значения такого продукта или заявок сделанных для его своим изготовлением. Furthermore, справка к продукту внутри бумага опубликовала центром санитарного просвещения Женщины (WHEC) and/or WomensHealthSection.com не образовывает гарантию или жироприказ того продукта или заявок своего изготовления. Факт что продукт, обслуживание, или компания разрекламированы в WomensHealthSection.com или любом другом издании WHEC, процитированы в бумаге, или exhibited на встречах WHEC не будет сослан к изготовлению в коллатеральной рекламе.Read More
Associate Director for Education Professor of Medicine and Medical Ethics Center for Medical Ethics and Health Policy Baylor College of Medicine One Baylor Plaza Houston, TX 77030, USA Laurence B. McCullough, Ph.D., has been Professor of Medicine and Medical Ethics in the Center for Medical Ethics and Health Policy, Professor of Family and Community Medicine, and a Faculty Associate of the Huffington Center on Aging at the Baylor College of Medicine in Houston, Texas, since July 1988, and Associate Director for Education of the Center for Medical Ethics and Health Policy since 2004. He is Adjunct Professor of Ethics in Obstetrics and Gynecology and of Public Health at the Weill Medical College of Cornell University in New York City, Adjunct Professor of Philosophy at Rice University, and holds medical staff appointments at St. Luke’s Episcopal Hospital, The Michael E. DeBakey Veterans Affairs Medical Center, and Texas Children’s Hospital. He won an American Council of Learned Societies Fellowship for 1995-1996 and was elected a Fellow the Gerontological Society of America in 1997 and of the Hastings Center in 2003. Dr. McCullough is a past president of the Society for Health and Human Values (1987-88), now the American Society for Bioethics and Humanities. Dr. McCullough teaches in the Progressive Care Unit of Texas Children’s Hospital, in the Medicine and Surgery services of The Michael E. DeBakey Veterans Affairs Medical Center, and in Baylor’s Departments of Pediatrics, Medicine, and Psychiatry. He is Director of the third-year elective in clinical ethics of Baylor’s national-award-winning four-year elective Ethics Track, the first of its kind among American medical schools. Dr. McCullough teaches the ethics courses in the certification and degree programs of the American College of Physician Executives. Dr. McCullough has published more than 275 peer-reviewed articles and 10 books. Medical Ethics: The Moral Responsibilities of Physicians, co-authored with Tom L. Beauchamp (Prentice-Hall, 1984), has been translated into Spanish (Barcelona, 1987) and Japanese (Tokyo, 1992). With Frank A. Chervenak, M.D. (Given Foundation Professor and Chairman of Obstetrics and Gynecology, Weill Medical College of Cornell University), he is co-author of Ethics in Obstetrics and Gynecology (Oxford University Press, 1994). He is co-editor with Nancy L. Wilson of Baylor’s Huffington Center on Aging of Long-Term Care Decisions: Ethical and Conceptual Dimensions (Johns Hopkins University Press, 1995). His Leibniz on Individuals and Individuation appeared in 1996 (Kluwer Academic Publishers). In 1998 his John Gregory and the Invention of Professional Medical Ethics and the Profession of Medicine and (as editor) John Gregory’s Writings on Medical Ethics and the Philosophy of Medicine appeared (Kluwer), as well as Surgical Ethics (Oxford), co-edited with Baruch A. Brody and James W. Jones. He is also co-editor with Baruch A. Brody, Mark Rothstein, and Mary Anne Bobinski of Medical Ethics: Codes, Opinions, and Statements (Bureau of National Affairs, 2000) and co-author with them of a companion volume commenting on these documents (BNA, 2001). With Robert B. Baker of Union College (Schenectady, New York) as co-editor, Dr. McCullough is presently preparing A History of Medical Ethics and The Cambridge Dictionary of Bioethics for Cambridge University Press. He is also preparing a second edition of Ethics in Obstetrics and Gynecology with Drs. Chervenak and John Coverdale, a Baylor psychiatrist. In addition, Dr. McCullough has published more than 40 original book chapters in scholarly volumes and 65 chapters in textbooks. Since coming to Baylor, Dr. McCullough has been or is Principal Investigator or Co-Investigator for grants and contracts from the NIH, Veterans Health Affairs, National Endowment for the Humanities, private foundations, and Baylor affiliated hospitals. He was Principal Investigator for «Enhancing the Autonomy of Vulnerable Subjects of Research,» funded by the NIH as part of the NIH, DOE and VA Consortium on Informed Consent Research (R01 04736) (1997-2002) and Co-Principal Investigator for «A History of Medical Ethics,» funded by the National Endowment for the Humanities (RZ-20525) and four private foundations (1999-2002). He is a member of the Ethics Committees of four of Baylor’s primary affiliated hospitals in the Texas Medical Center: St. Luke’s Episcopal Hospital, The Michael E. DeBakey Veterans Affairs Medical Center, The Methodist Hospital, and Texas Children’s Hospital. Since 1999, he has also served as Director of the Ethics Consultation Program at St. Luke’s Episcopal Hospital. Dr. McCullough received his A.B. in Art History from Williams College (1969) and his Ph.D. in Philosophy from the University of Texas at Austin (1975) and held a post-doctoral fellowship at The Hastings Center (1975-1976). He has held prior appointments on the medical and philosophy faculties at Texas A&M University (1976-1979) and Georgetown University (1979-1988), where he was a Senior Research Scholar in the Kennedy Institute of Ethics. He is married to Linda J. Quintanilla, Ed.D., who teaches history at North Harris College in Houston, .Read More
J. Donald Woodruff Professor of Gynecology, The Johns Hopkins Hospital, Department of Gynecology and Obstetrics, Baltimore, MD (USA) Education/Training: Swarthmore College B.A. 1954 English Literature Cornell University M.D. 1958 Medicine Bellevue Hospital (Cornell Medical Division) Internship 1958-1959 Medicine Kings County Hospital Residency 1959-1963 OB/GYN Worcester Foundation for Experimental Biology Fellowship 1961-1962 Reproductive Biology Professional Experience: 1962-63 Assistant Instructor, Department of Obstetrics and Gynecology State University of New York Downstate Medical Center 1965-66 Associate, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine 1966-70 Assistant Professor, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine 1970-71 Associate Professor, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine 1971-84 Professor, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine 1981-82 Visiting Professor, Department of Obstetrics and Gynecology, Kyoto University Medical School, Japan (sabbatical- leave) 1971-84 Professor Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine & Chairman Department of Obstetrics and Gynecology Pennsylvania Hospital 1987 Visiting Professor, Department of Obstetrics and Gynecology, Keio University, Tokyo, Japan 1991-98 Joint Appointment, Professor, Department of Population Dynamics, The Johns Hopkins University School of Hygiene and Public Health 1994-Present J. Donald Woodruff Professor of Gynecology, Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine 1999-Present Joint Appointment, Department of Biochemistry, The Johns Hopkins University School of Hygiene and Public Health. Honors and Awards: 1970-71 The Christian R. and Mary F. Lindback Foundation Distinguished Teaching Award, University of Pennsylvania School of Medicine 1970 Honorary Degree — Master of Arts — University of Pennsylvania 1974 Alpha Omega Alpha — Elected to Faculty Membership 1977 Clarence C. Briscoe Teaching Award- Pennsylvania Hospital 1984 Serono Lecturer, 40th Annual Meeting, American Fertility Society 1988 Third Memorial John Rock Lecturer, University of Pennsylvania School of Medicine 1988 Eighteenth Annual William Studdiford Visiting Professor, New York University School of Medicine 1988 Eleventh Annual Robert B. Greenblatt Lecturer, Medical College of Georgia 1991 Ninth Isadore Seigel Memorial Lecturer, University of Maryland School of Medicine 1995 Elected to Membership, Institute of Medicine, National Academy of Science 1996 First Honored Alumnus Lecturer, Alumni Day, Department of Obstetrics and Gynecology, SUNY Health Science Center at Brooklyn, September 27, 1996 1996 Alvin F. Goldfarb Lecturer, Vanderbilt University, October 26, 1996 1997 25th Annual S. Leon Israel Visiting Lecturer, Pennsylvania Hospital, June 26, 1997 1997 11th Annual Griff T. Ross Memorial Lecturer, NIH, September 26, 1997 1999 16th Annual Howard and Georgeanna Jones Lectureship, Johns Hopkins, December 9, 1999 2000 Poly Prep Country Day School; Distinguished Achievement Award; April 29, 2000 2000 P.A.R.E.S. Philadelphia Area Reproductive Endocrinology Society Recognition of Excellence Award; May 4, 2000 2002 Nokes Lecturer; University of Virginia Department of Obstetrics and Gynecology; May 10-11, 2002 Publications: Books MODERN TRENDS IN INFERTILITY AND CONCEPTION CONTROL. Vol. 1 Ed. by Wallach, E.E. and Kempers, R.D., Williams and Wilkins Co. Baltimore, Md. (1979) MODERN TRENDS IN INFERTILITY AND CONTRACEPTION CONTROL. Vol. II Ed. by Wallach, E.E. and Kempers, R.D., Harper and Row Publishers, Philadelphia, Pa. (1982) MODERN TRENDS IN INFERTILITY AND CONTRACEPTION CONTROL. Vol. III Ed by Wallach, E.E. and Kempers, R.D. Yearbook Medical Publishers, Chicago, IL (1985) MODERN TRENDS IN INFERTILITY AND CONTRACEPTION CONTROL. Vol. IV Ed by Wallach, E.E. and Kempers, R.D., Yearbook Medical Publishers, Chicago, IL (1988) REPRODUCTIVE MEDICINE AND SURGERY. Edited by Wallach, E.E. and Zacur H.A. Mosby Yearbook Medical Publishers, St. Louis, MO (1994) THE JOHNS HOPKINS MANUAL OF GYNECOLOGY & OBSTETRICS, first edition, edited by Lambrou NC, Morse AN, Fox HE, Wallach EE, Lippincott Williams and Wilkins, Philadelphia, PA (1999) THE JOHN HOPKINS MANUAL OF GYNECOLOGY & OBSTETRICS, second edition, edited by Bankowski BJ, Hearne AE, Lambrou NC, Fox HE, Wallach EE. Lippincott Williams and Wilkins, Philadelphia PA (2002) HYSTERECTOMY: EXPLORING YOU OPTIONS. Wallach EE, Eisenberg E. Johns Hopkins University Press, Baltimore, MD (2003) Bibliography Vlahos NP, Dragisic KG, Wallach EE, Burrough FH, Fluck S, Rosenthal DL. Clinical significance of atypical squamous cells of undermined significance: an analysis based on histologic diagnosis. The Amer. J of Obstet and Gynecol 2000;185:855-900. Phelps JY, Wallach EE, and Moghissi KS. Evaluation and Management of Infertility in (Ransom SB {Ed}) Practical Strategies in Infertility. Philadelphia, WB Saunders and Company, 2000, PP 609-627. Edwards BE, Gearhart JD, Wallach EE. The human pluripotent stem cell: Impact on Medicine and Society. Fertil Steril 2000; 74(1): 1-7 Jurema MW, Wallach EE, Blumenthal PD. Miferistone for Medical Abortion: A Review. Postgraduate Obstetrics and Gynecology, June 2001, Volume 21, Number 13. Jurema MW, Valhos N, Wallach EE. Reproductive Health and Cystic Fibrosis. Postgraduate Obstetrics and Gynecology, January 2001, Volume 21, Number 2. Whelan III, J, Vlahos NP, Jurema MW, Wallach EE. Contemporary Management of Leiomyomata. W.B. Saunders, (eds. Ransom S, Dombrowski M, Evans M, Ginsburg K). Contemporary Therapy in Obstetrics and Gynecology. 2002;367-370. Posada MN, Valhos NP, Jurema MW, Bracero NJ, Wallach EE, Garcia JE. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization. Fertil Steril. 2003 July; 80(1):103-10. Vlahos NP, Wallach EE. Uterine Myomas An Overview of Development, Clinical Features and Management. Obstetrics and Gynecology. 2004 August; 104 (2): 393-406. Zhao Y, Valhos N, Wyncott D, Petrella C, Garcia J, Zacur H, Wallach EE. Impact of semen characteristics on the success of intrauterine insemination. Journal of Assisted Reproduction and Genetics. 2004; Vol 21 (no. 5); 143-148. Lyerly A, Belsford E, Bankowski B, Faden R, Wallach E. A quantitative study of individuals’ attitudes regarding their cryopreserved embryos. JFFS Congress Proceedings (in press 2004). Bacero JH, Vlahos NP, Jurema MW, Wallach EE, Garcia JE. Triggering ovulation with two doses of a GnRH agonist after treatment with a GnRH antagonist in IVF-ET. Human Reproduction (Submitted). Lai T-H, Shih I-M, Vlahos N, Ho Z, Wallach EE, Zhao J. Differential expression of L-selectin ligands in the endometrium during the menstrual cycle (in preparation). Abstracts: Posada M, Jurema M, Valhos N, Bracero N, Wallach EE, Garcia J. Should women with poor prognostic factors for controlled ovarian hyper-stimulation undergo in vitro fertilization (COH-IVF) using Ganirelix? American Society for Reproductive Medicine 2001 Annual Meeting. Wyncott D, Vlahos N, Garcia J, Zacur H, Wallach EE, Zhao Y. Intrauterine insemination: Which sperm characteristic matters? ASRM, October 2003. Bankowski B, Zhao Y, Zacur H, Wallach E, Garcia J, Vlahos N. High pregnancy rates with GnRH antagonists and oocyte donors. (ESHRE), Madrid, Spain, June 2003. Coker L, Lawler C, Zhao Y, Bankowski B, Wallach E, Vlahos N. Follicular diameter and hCG administration do not affect pregnancy rates after clomiphene citrate and intrauterine insemination. ASRM Poster Presentation San Antonio Texas, October 2003. Jurema M, Vieira A, Bankowski B, Zhao Y, Wallach E, Zacur H. Ejaculatory abstinence less than 3 days results in a higher pregnancy rate (PR) following intrauterine insemination (IUI). ASRM Oral Presentation, San Antonio, Texas. October 2003. Wyncott D, Vlahos N, Garcia J, Zacur HA, Wallach EE, Zhao Y. Intrauterine insemination; which sperm characteristics matter? ASRM Oral Presentation. San Antonio Texas. October 2003. Bankowski B, Bracero N, King J, Garcia J, Wallach EE, Vlahos N. Ovulation triggering of oocyte maturation with leuprolide acetate versus Human Chorionic Gonadotropin (hCG). Scientific Program, Berlin, Germany, June 27-30, 2004.Read More
председатель, Department of Obstetrics and Gynecology St. Elizabeth’s Medical Center Boston, MA (USA) Education: Graduated from Harvard College, 1952-56 Served in United States Navy (Ensign-Lt jg), 1956-58 Boston University School of Medicine, 1958-62 Internship/residency surgery St. Vincent’s Hospital NY, NY, 1962-64 Ob/Gyn residency St. Vincent’s Hospital NY, NY, 1964-68 Experience: Clinical Professor of Ob/Gyn, Tufts University School of Medicine President, Obstetrical Society of Boston, 1999-2000 Chairman, Massachusetts Section ACOG, 1998-2002 Chairman, Department of Ob/Gyn, St. Elizabeth’s Medical Center, Boston MA St. Elizabeth’s Medical Center is devoted to women’s health care issues and welcomes projects related to safe motherhood from all over the world. Our residency program has residents from various countries and ethnic backgrounds. Our diversity is our strength.Read More
